Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Compound astragalus polysaccharide soluble powder for preventing and treating avian influenza

An astragalus polysaccharide, soluble technology, applied in powder delivery, pharmaceutical formulations, allergic diseases and other directions, to achieve the effects of abundant raw materials, low price and good use effect

Pending Publication Date: 2021-12-07
河南纳瑞森生物药业有限公司 +2
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0012] In view of the above situation, in order to solve the defects of the prior art, the object of the present invention is to provide a compound astragalus polysaccharide soluble powder for preventing and treating avian influenza in birds, which can effectively solve the problem of medication for avian influenza

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compound astragalus polysaccharide soluble powder for preventing and treating avian influenza

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0017] When the present invention is implemented, the following weights can be used: 550 g of astragalus polysaccharide, 180 g of Achyranthes bidentata polysaccharide, 110 g of cat's claw polysaccharide and 75 g of semen japonicus cream are used as raw material drugs, and the above-mentioned raw materials are mixed and dried, and the weight of the raw material drugs is added. 3% auxiliary material, the auxiliary material is powdered sugar and dextrin mixed at a ratio of 4:1, thoroughly mixed, pulverized, dried at 60°C, and passed through an 80-mesh sieve to obtain the compound astragalus polysaccharide soluble powder.

Embodiment 2

[0019] When the present invention is implemented, the following weights can be used: 600g of astragalus polysaccharide, 200g of Achyranthes bidentata polysaccharide, 120g of cat's claw polysaccharide and 80g of semen japonicus cream as the raw material drug, the above-mentioned raw materials are mixed and dried, and the weight of the raw material drug is added 3% auxiliary material, the auxiliary material is powdered sugar and dextrin mixed at a ratio of 4:1, thoroughly mixed, pulverized, dried at 60°C, and passed through an 80-mesh sieve to obtain the compound astragalus polysaccharide soluble powder.

Embodiment 3

[0021] When the present invention is implemented, the following weights can also be used: 650g of astragalus polysaccharide, 220g of Achyranthes bidentata polysaccharide, 130g of cat's claw polysaccharide and 85g of semen japonicus cream as the raw material drug, the above-mentioned raw materials are mixed and dried, and the raw material drug is added 3% by weight of auxiliary materials, the auxiliary materials are powdered sugar and dextrin, fully mixed at a ratio of 4:1, pulverized, dried at 60°C, and passed through an 80-mesh sieve to obtain the compound astragalus polysaccharide soluble powder.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to compound astragalus polysaccharide soluble powder for preventing and treating bird flu, which can effectively solve the problem of medicine use for avian influenza, and adopts the technical scheme that the soluble powder is prepared by taking 550-650g of astragalus polysaccharide, 180-220g of achyranthes bidentata polysaccharide, 110-130g of radix ranunculi ternati polysaccharide and 75-85g of semen momordicae cream as raw material medicines and adding auxiliary materials accounting for 3% of the weight of the raw material medicines, wherein the auxiliary material is prepared by uniformly mixing powdered sugar and dextrin according to the weight ratio of 4: 1, crushing, drying at 60 DEG C, and sieving with a 80-mesh sieve. The traditional Chinese veterinary medicine is rich in raw materials, low in price, safe in medication, free of toxic and side effects and good in use effect, and is an innovation of traditional Chinese veterinary medicines for preventing and treating avian influenza.

Description

technical field [0001] The invention relates to veterinary medicine and pharmaceutical technology, in particular to a compound astragalus polysaccharide soluble powder for preventing and treating poultry avian influenza. Background technique [0002] The main targets of avian influenza virus infection are birds, but in recent years, especially H5N1 highly pathogenic avian influenza virus can cause infection and death of a variety of mammals, such as avian influenza in tigers in zoos in my country and tigers and leopards in zoos in Thailand The morbidity and death of other animals such as pigs, cats, dogs, etc. have also been reported from time to time. Of course, among the avian influenza virus infections in many mammals, the swine avian influenza infection is the most harmful to humans. Once human influenza virus and avian influenza virus co-infect pigs, it is likely to produce mutant strains that are transmitted and circulated among humans. The research shows that the HA,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/42A61K31/715A61K9/14A61P31/16A61P37/04A61P1/12A61P1/00A61P31/14A61P31/12
CPCA61K36/42A61K31/715A61K9/146A61P31/16A61P37/04A61P1/12A61P1/00A61P31/14A61P31/12A61K2300/00
Inventor 杨成祥赵云生赵蕾
Owner 河南纳瑞森生物药业有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com